i-123-adam
Small moleculeexperimentalImaging agent
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
3
Phase 3
1
Phase 4
0
Earliest trial started May 1, 2010 (NCT01548937)
Timeline
Indications
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 123-iodine
Oral
No
Parenteral
No
Topical
No
Also known as
- 123i-adam
- 123i-adam
- i-123 adam
- i-123-adam
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01160263 | Phase 3 | Oct 1, 2012 | University of Paris |
| NCT02473783 | Phase 2 | Oct 1, 2011 | Government of Taiwan |
| NCT01548937 | Phase 2 | May 1, 2010 | Chang Gung University |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Chang Gung University | Academic/Hospital | 1 | 1 | 1 | 2010 |
| Government of Taiwan | Government | 1 | 1 | 1 | 2011 |
| University of Paris | Academic/Hospital | 1 | 1 | 1 | 2012 |
3 organizations
Page 1 / 1